[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE9801368D0 - New use - Google Patents

New use

Info

Publication number
SE9801368D0
SE9801368D0 SE9801368A SE9801368A SE9801368D0 SE 9801368 D0 SE9801368 D0 SE 9801368D0 SE 9801368 A SE9801368 A SE 9801368A SE 9801368 A SE9801368 A SE 9801368A SE 9801368 D0 SE9801368 D0 SE 9801368D0
Authority
SE
Sweden
Prior art keywords
value
glucocorticosteroid
reversibility
copd
patients
Prior art date
Application number
SE9801368A
Other languages
Swedish (sv)
Inventor
Ralph Brattsand
Stefan Ohlsson
Carl Goeran Persson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9801368A priority Critical patent/SE9801368D0/en
Publication of SE9801368D0 publication Critical patent/SE9801368D0/en
Priority to CN99807636A priority patent/CN1306429A/en
Priority to JP2000544330A priority patent/JP2002512193A/en
Priority to BR9909786-9A priority patent/BR9909786A/en
Priority to PCT/SE1999/000426 priority patent/WO1999053926A1/en
Priority to CA002329008A priority patent/CA2329008A1/en
Priority to AU30625/99A priority patent/AU3062599A/en
Priority to EP99912204A priority patent/EP1073441A1/en
Priority to ARP990101816A priority patent/AR018191A1/en
Priority to HK02100375.3A priority patent/HK1038703A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the use of a glucocorticosteroid for the manufacture of a medicament for treating chronic obstructive pulmonary disease (COPD) in patients having an FEV1.0 value > 65 % of predicted value and < 10 % reversibility in bronchodilator test. The invention further relates to a method for treatment of COPD in patients having an FEV1.0 value > 65 % of predicted value and < 10 % reversibility in bronchodilator test, where a therapeutically effective amount of a glucocorticosteroid is administered to a patient in need of such treatment.
SE9801368A 1998-04-20 1998-04-20 New use SE9801368D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9801368A SE9801368D0 (en) 1998-04-20 1998-04-20 New use
CN99807636A CN1306429A (en) 1998-04-20 1999-03-18 Use of glucocorticosteriod for mfg. medicament for treating mild/early forms of COPD (chronic obstructive pulmonary disease)
JP2000544330A JP2002512193A (en) 1998-04-20 1999-03-18 Use of carbohydrate corticosteroids for the manufacture of a medicament for treating mild / early forms of COPD (chronic obstructive pulmonary disease)
BR9909786-9A BR9909786A (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid to manufacture a drug to treat mild / early forms of copd (chronic obstructive pulmonary disease
PCT/SE1999/000426 WO1999053926A1 (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
CA002329008A CA2329008A1 (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
AU30625/99A AU3062599A (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
EP99912204A EP1073441A1 (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
ARP990101816A AR018191A1 (en) 1998-04-20 1999-04-20 USE OF GLUCOCORTICOSTEROIDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASES
HK02100375.3A HK1038703A1 (en) 1998-04-20 2002-01-17 Use of a gluococorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801368A SE9801368D0 (en) 1998-04-20 1998-04-20 New use

Publications (1)

Publication Number Publication Date
SE9801368D0 true SE9801368D0 (en) 1998-04-20

Family

ID=20411015

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801368A SE9801368D0 (en) 1998-04-20 1998-04-20 New use

Country Status (10)

Country Link
EP (1) EP1073441A1 (en)
JP (1) JP2002512193A (en)
CN (1) CN1306429A (en)
AR (1) AR018191A1 (en)
AU (1) AU3062599A (en)
BR (1) BR9909786A (en)
CA (1) CA2329008A1 (en)
HK (1) HK1038703A1 (en)
SE (1) SE9801368D0 (en)
WO (1) WO1999053926A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9912534D0 (en) 1999-05-29 1999-07-28 Glaxo Group Res Ltd Novel prognostic surrogate
AR029189A1 (en) * 1999-11-02 2003-06-18 Smithkline Beecham Corp USE OF A PHOSPHODIESTERASE 4 INHIBITOR AND AN ANTI-INFLAMMATORY CORTICOESTEROID IN COMBINED FORM, SEPARATELY OR SEPARATELY SEQUENTIALLY FOR THE PREPARATION OF A MEDICINAL PRODUCT
DE60323138D1 (en) 2002-12-12 2008-10-02 Nycomed Gmbh COMBINATION MEDICAMENT OF R, R-FORMOTEROL AND CICLESONIDE
WO2004070058A1 (en) * 2003-02-03 2004-08-19 Bayer Healthcare Ag Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of copd
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
WO2005025578A1 (en) 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
EP1667687A1 (en) * 2003-09-26 2006-06-14 Schering Corporation Pulmonary disease treatment
CA2563556C (en) * 2004-04-20 2013-01-29 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient

Also Published As

Publication number Publication date
AU3062599A (en) 1999-11-08
AR018191A1 (en) 2001-10-31
CN1306429A (en) 2001-08-01
BR9909786A (en) 2000-12-19
CA2329008A1 (en) 1999-10-28
WO1999053926A1 (en) 1999-10-28
JP2002512193A (en) 2002-04-23
HK1038703A1 (en) 2002-03-28
EP1073441A1 (en) 2001-02-07

Similar Documents

Publication Publication Date Title
AU684087B2 (en) Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
Cooney et al. Scaphoid nonunion: role of anterior interpositional bone grafts
DE69912434D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FUNCTIONAL DYSPEPSY AND / OR THE IRRIDAL SYNDROME AND THE USE OF NEW SUBSTANCES IN THIS COMPOSITION
BR0008276A (en) Combinations of formoterol and fluticasone propionate for asthma
BR0015974A (en) Use of levetiracetam, pharmaceutical composition, use of a pharmaceutical composition and methods to treat a patient administered with an amount of at least one compound and a disease and to selectively potentiate the therapeutic effect of a compound
ATE330589T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING RESVERATROL FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY TRACT
BR0111591A (en) Compounds, pharmaceutical composition, and methods for elevating the growth hormone plasma level in a mammal, for the treatment of growth hormone secretion deficiency, for the treatment of growth retardation in children, for the treatment of metabolic disorders growth hormone secretion deficiency, particularly in elderly patients, and to promote wound healing, surgical recovery or recovery from debilitating diseases
EA200700232A1 (en) HIGH-SELECTIVE INHIBITORS OF REVERSE CAPTURE OF NOREPINEFRIN AND METHODS OF THEIR APPLICATION
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
BR9811825A (en) Use of lactobacillus to reduce the level of fibrinogen in the blood
CA2467159A1 (en) Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
BR9713921A (en) Compound, pharmaceutical composition, process for logician capable of being modulated through factor xa inhibition
ATE309795T1 (en) ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF BREATHING DISORDERS DURING SLEEP
SE9801368D0 (en) New use
Harper et al. Non-union of Colles' fracture: report of two cases
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
PE11399A1 (en) COMBINATION OF LORATADINE AND A DECONESCENTANT FOR THE TREATMENT OF ASTHMA
MXPA03011702A (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases.
BR9809678A (en) Triptolyte derivatives useful in the treatment of autoimmune diseases
SE9902597D0 (en) New use
Ejnell et al. Treatment of postoperative pain with diclofenac in uvulopalatopharyngoplasty
BR9809673A (en) Triptolide derivatives useful in the treatment of autoimmune diseases
EA200200518A1 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF PULMONARY DISEASES
RU98114080A (en) BIOLOGICALLY ACTIVE ETHANAMINES OF BENZOTIAZOLONE
SE8903529D0 (en) MEDICAL USE